Trebananib Completed Phase 2 Trials for Endometrial Clear Cell Adenocarcinoma / Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation / Endometrioid Stromal Sarcoma / Endometrial Serous Adenocarcinoma / Recurrent Uterine Corpus Carcinoma / Endometrial Adenosquamous Carcinoma / Endometrial Adenocarcinomas Treatment